{
  "abstract": null,
  "abstract_shown": false,
  "affiliations": [
    "Mayo Clinic, Phoenix, AZ, USA",
    "1The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
    "Ludwig-Maximilians University Munich, Munich, Bavaria, Germany",
    "12 German Centre for Neurodegenerative Diseases, Munich, Germany",
    "German Center for Neurodegenerative Diseases (DZNE), Munich, Bavaria, Germany",
    "Denali Therapeutics, Inc., South San Francisco, CA, USA"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 9,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Pravesh Gupta"
    },
    {
      "affs": [
        1
      ],
      "name": "Krishna Bhat"
    },
    {
      "affs": [
        2
      ],
      "name": "Christian Haass"
    },
    {
      "affs": [
        3
      ],
      "name": "Matthias Brendel"
    },
    {
      "affs": [
        0
      ],
      "name": "Tyler M Johnston"
    },
    {
      "affs": [
        0
      ],
      "name": "Yoshinari Osada"
    },
    {
      "affs": [
        0
      ],
      "name": "Gabrielle Kizeev"
    },
    {
      "affs": [
        4
      ],
      "name": "Kai Schlepckow"
    },
    {
      "affs": [
        5
      ],
      "name": "Kathryn Monroe"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/8w9xmtn3qsy09.bib",
  "cited_by": 0,
  "doi": "10.1136/jitc-2026-sitc2026.0606",
  "fulltext_url": null,
  "id": "8w9xmtn3qsy09",
  "issns": [
    "2051-1426"
  ],
  "landing_url": "https://doi.org/10.1136/jitc-2026-sitc2026.0606",
  "language": "en",
  "licence": "CC-BY",
  "licence_label": "CC BY",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "RC254-282"
    ],
    [
      "openalex",
      "2730|Cancer Immunotherapy and Biomarkers"
    ]
  ],
  "openalex": "W7225322156",
  "pdf_url": "https://jitc.bmj.com/content/14/Suppl_2/A685.full.pdf",
  "pmcid": null,
  "pmid": null,
  "published": "2026-11-08",
  "publisher": "BMJ Publishing Group",
  "ris": "https://research.draconitic.com/paper/8w9xmtn3qsy09.ris",
  "sources": [
    {
      "first_seen": "2026-11-09T14:21:27Z",
      "native_id": "0c6071f4155d4f41bfdf0d4878889499",
      "source": "doaj",
      "url": "https://doi.org/10.1136/jitc-2026-sitc2026.0606"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2730|Cancer Immunotherapy and Biomarkers",
      "subfield": "oncology"
    }
  ],
  "title": "606 Transport vehicle-enabled TREM2 agonist therapy potentiates anti-tumor immunity in preclinical mouse models of GBM",
  "title_text": "606 Transport vehicle-enabled TREM2 agonist therapy potentiates anti-tumor immunity in preclinical mouse models of GBM",
  "type": "peer-reviewed",
  "updated_at": "2026-11-09T14:21:27Z",
  "url": "https://research.draconitic.com/paper/8w9xmtn3qsy09",
  "venue": "Journal for ImmunoTherapy of Cancer",
  "versions": []
}